493 related articles for article (PubMed ID: 29885652)
21. Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome.
Machii M; Satoh H; Shiraki K; Saotome M; Urushida T; Katoh H; Takehara Y; Sakahara H; Ohtani H; Wakabayashi Y; Ukigai H; Tawarahara K; Hayashi H
Magn Reson Imaging; 2014 Feb; 32(2):118-24. PubMed ID: 24315973
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of left and right ventricular ejection and filling parameters of the heart using cine-MRI with breath holding technique. Clinical study of 42 patients with cardiomyopathy and coronary heart disease].
Rominger MB; Bachmann GF; Geuer M; Puzik M; Ricken WW; Rau WS
Rofo; 1999 Jun; 170(6):534-41. PubMed ID: 10420902
[TBL] [Abstract][Full Text] [Related]
23. Endomyocardial miR-133a levels correlate with myocardial inflammation, improved left ventricular function, and clinical outcome in patients with inflammatory cardiomyopathy.
Besler C; Urban D; Watzka S; Lang D; Rommel KP; Kandolf R; Klingel K; Thiele H; Linke A; Schuler G; Adams V; Lurz P
Eur J Heart Fail; 2016 Dec; 18(12):1442-1451. PubMed ID: 27292200
[TBL] [Abstract][Full Text] [Related]
24. Circulating microRNA-29-5p can add to the discrimination between dilated cardiomyopathy and ischaemic heart disease.
Brundin M; Wågsäter D; Alehagen U; Carlhäll CJ
ESC Heart Fail; 2021 Oct; 8(5):3865-3874. PubMed ID: 34173728
[TBL] [Abstract][Full Text] [Related]
25. Circulating microRNAs as novel biomarkers for dilated cardiomyopathy.
Wang H; Chen F; Tong J; Li Y; Cai J; Wang Y; Li P; Hao Y; Tian W; Lv Y; Chong J; Yang J
Cardiol J; 2017; 24(1):65-73. PubMed ID: 27748501
[TBL] [Abstract][Full Text] [Related]
26. A systematic review of microRNAs in patients with hypertrophic cardiomyopathy.
Scolari FL; Faganello LS; Garbin HI; Piva E Mattos B; Biolo A
Int J Cardiol; 2021 Mar; 327():146-154. PubMed ID: 33212095
[TBL] [Abstract][Full Text] [Related]
27. A novel missense mutation in the myosin binding protein-C gene is responsible for hypertrophic cardiomyopathy with left ventricular dysfunction and dilation in elderly patients.
Konno T; Shimizu M; Ino H; Matsuyama T; Yamaguchi M; Terai H; Hayashi K; Mabuchi T; Kiyama M; Sakata K; Hayashi T; Inoue M; Kaneda T; Mabuchi H
J Am Coll Cardiol; 2003 Mar; 41(5):781-6. PubMed ID: 12628722
[TBL] [Abstract][Full Text] [Related]
28. Circulating microRNA as a biomarker for recovery in pediatric dilated cardiomyopathy.
Miyamoto SD; Karimpour-Fard A; Peterson V; Auerbach SR; Stenmark KR; Stauffer BL; Sucharov CC
J Heart Lung Transplant; 2015 May; 34(5):724-33. PubMed ID: 25840506
[TBL] [Abstract][Full Text] [Related]
29. Electrocardiographic features differentiating dilated cardiomyopathy from hypertrophic cardiomyopathy.
Kamiyama N; Nezuo S; Sawayama T; Kawahara Y; Samukawa M; Suetuna R; Saitou Y
J Electrocardiol; 1997 Oct; 30(4):301-6. PubMed ID: 9375906
[TBL] [Abstract][Full Text] [Related]
30. Artificial intelligence study on left ventricular function among normal individuals, hypertrophic cardiomyopathy and dilated cardiomyopathy patients using 1.5T cardiac cine MR images obtained by SSFP sequence.
Guo J; Lu H; Chen Y; Zeng M; Jin H
Br J Radiol; 2022 May; 95(1133):20201060. PubMed ID: 35084208
[TBL] [Abstract][Full Text] [Related]
31. Circulating miRNA as novel markers for diastolic dysfunction.
Nair N; Kumar S; Gongora E; Gupta S
Mol Cell Biochem; 2013 Apr; 376(1-2):33-40. PubMed ID: 23247724
[TBL] [Abstract][Full Text] [Related]
32. [The levels of certain circulating microRNAs in hypertrophic cardiomyopathy are associated with echocardiographic parameters].
Pisklova MV; Baulina NM; Kiselev IS; Zateyshchikov DA; Favorova OO; Chumakova OS
Ter Arkh; 2023 May; 95(4):302-308. PubMed ID: 38158977
[TBL] [Abstract][Full Text] [Related]
33. ERBB4 and Multiple MicroRNAs That Target ERBB4 Participate in Pregnancy-Related Cardiomyopathy.
Feyen E; Ricke-Hoch M; Van Fraeyenhove J; Vermeulen Z; Scherr M; Dugaucquier L; Viereck J; Bruyns T; Thum T; Segers VFM; Hilfiker-Kleiner D; De Keulenaer GW
Circ Heart Fail; 2021 Jul; 14(7):e006898. PubMed ID: 34247489
[TBL] [Abstract][Full Text] [Related]
34. Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect.
Tadros R; Francis C; Xu X; Vermeer AMC; Harper AR; Huurman R; Kelu Bisabu K; Walsh R; Hoorntje ET; Te Rijdt WP; Buchan RJ; van Velzen HG; van Slegtenhorst MA; Vermeulen JM; Offerhaus JA; Bai W; de Marvao A; Lahrouchi N; Beekman L; Karper JC; Veldink JH; Kayvanpour E; Pantazis A; Baksi AJ; Whiffin N; Mazzarotto F; Sloane G; Suzuki H; Schneider-Luftman D; Elliott P; Richard P; Ader F; Villard E; Lichtner P; Meitinger T; Tanck MWT; van Tintelen JP; Thain A; McCarty D; Hegele RA; Roberts JD; Amyot J; Dubé MP; Cadrin-Tourigny J; Giraldeau G; L'Allier PL; Garceau P; Tardif JC; Boekholdt SM; Lumbers RT; Asselbergs FW; Barton PJR; Cook SA; Prasad SK; O'Regan DP; van der Velden J; Verweij KJH; Talajic M; Lettre G; Pinto YM; Meder B; Charron P; de Boer RA; Christiaans I; Michels M; Wilde AAM; Watkins H; Matthews PM; Ware JS; Bezzina CR
Nat Genet; 2021 Feb; 53(2):128-134. PubMed ID: 33495596
[TBL] [Abstract][Full Text] [Related]
35. Serum microRNA profiles in cats with hypertrophic cardiomyopathy.
Weber K; Rostert N; Bauersachs S; Wess G
Mol Cell Biochem; 2015 Apr; 402(1-2):171-80. PubMed ID: 25573325
[TBL] [Abstract][Full Text] [Related]
36. [Unclassified cardiomyopathies: subspecies and their transformation].
Ikeda Y; Kawai S; Okada R; Yamaguchi H
J Cardiol; 1998 Feb; 31(2):91-7. PubMed ID: 9513036
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-30d and -483-3p for bi-ventricular remodelling and miR-126-3p for pulmonary hypertension in advanced heart failure.
Gallo A; Agnese V; Sciacca S; Scardulla C; Cipriani M; Pilato M; Oh JK; Pasta S; Maalouf J; Conaldi PG; Bellavia D
ESC Heart Fail; 2024 Feb; 11(1):155-166. PubMed ID: 37864482
[TBL] [Abstract][Full Text] [Related]
38. Progression from hypertrophic obstructive cardiomyopathy to typical dilated cardiomyopathy-like features in the end stage.
Fujiwara H; Onodera T; Tanaka M; Shirane H; Kato H; Yoshikawa J; Osakada G; Sasayama S; Kawai C
Jpn Circ J; 1984 Nov; 48(11):1210-4. PubMed ID: 6542151
[TBL] [Abstract][Full Text] [Related]
39. [Left ventricular diastolic reserve during acute pressure loading in hypertrophic cardiomyopathy and dilated cardiomyopathy].
Yokote Y; Okamoto M; Sakura E; Shimamoto H; Amioka H; Yamagata T; Hashimoto M; Tsuchioka Y; Matsuura H; Kajiyama G
J Cardiol; 1988 Dec; 18(4):1051-60. PubMed ID: 3267714
[TBL] [Abstract][Full Text] [Related]
40. [Hypertrophic cardiomyopathy with left ventricular dilatation].
Iwami G; Miyazaki Y; Matsuyama K; Shida M; Ooga M; Furuta Y; Ikeda H; Toshima H; Chiba M; Koga Y
J Cardiol; 1988 Jun; 18(2):319-28. PubMed ID: 3249261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
